Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Stentoft · SciRah

Researcher profile · Semantic Scholar

J. Stentoft

Share profile

J. Stentoft — researcher profile on SciRah

h-index: 21
Works: 100
Citations: 2,318

Most-cited papers

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.
C. Abboud, E. Berman, Adam D. Cohen, J. Cortes +115 more
2013Blood587 citations Open access
Semantic Scholar
Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study
A. Hochhaus, T. Masszi, F. Giles, J. Radich +16 more
2017Leukemia276 citations Open access
Semantic Scholar
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia.
B. Simonsson, T. Gedde-Dahl, B. Markevärn, K. Remes +24 more
2011Blood186 citations Open access
Semantic Scholar
Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study
D. Ross, T. Masszi, M. Gómez-Casares, A. Hellmann +15 more
2018Journal of Cancer Research and Clinical Oncology146 citations Open access
Semantic Scholar
Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML.
Rebecca Warfvinge, L. Geironson, Mikael N. E. Sommarin, Stefan Lang +10 more
2017Blood128 citations Open access
Semantic Scholar
The Toxicity of Cytarabine
J. Stentoft
1990Drug Safety97 citations
Semantic Scholar
Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial
J. Radich, A. Hochhaus, T. Masszi, A. Hellmann +14 more
2021Leukemia88 citations Open access
Semantic Scholar
Kinetics of BCR‐ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real‐time polymerase chain reaction
J. Stentoft, N. Pallisgaard, E. Kjeldsen, M. Holm +2 more
2001European Journal of Haematology66 citations
Semantic Scholar
Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients
H. Hjorth-Hansen, J. Stentoft, J. Richter, P. Koskenvesa +16 more
2016Leukemia58 citations Open access
Semantic Scholar
Minimal residual core binding factor AMLs by real time quantitative PCR--initial response to chemotherapy predicts event free survival and close monitoring of peripheral blood unravels the kinetics of relapse.
J. Stentoft, P. Hokland, M. Ostergaard, H. Hasle +1 more
2006Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis56 citations
Semantic Scholar
Cerebral oedema as a possible complication of treatment with imatinib.
M. Ebnöether, J. Stentoft, James Ford, L. Buhl +1 more
2002The Lancet55 citations
Semantic Scholar
Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses
T. Knudsen, V. Skov, K. Stevenson, L. Werner +28 more
2021Blood Advances51 citations Open access
Semantic Scholar
Evaluation of platelet function in thrombocytopenia
M. T. Skipper, P. Rubak, J. Stentoft, A. Hvas +1 more
2018Platelets46 citations
Semantic Scholar
Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib
Stein-Erik Gullaksen, J. Skavland, S. Gavasso, V. Tosevski +25 more
2017Haematologica29 citations Open access
Semantic Scholar
Wilms' tumor 1 mutation accumulated during therapy in acute myeloid leukemia: biological and clinical implications
C. Nyvold, J. Stentoft, Karin Brændstrup, D. Melsvik +4 more
2006Leukemia29 citations
Semantic Scholar
Lupus anticoagulant and anticardiolipin antibodies in an obstetric population
P. Rix, J. Stentoft, N. Aunsholt, M. Dueholm +2 more
1992Acta Obstetricia et Gynecologica Scandinavica27 citations
Semantic Scholar
Survival of patients with chronic myeloproliferative neoplasms and new primary cancers: a population-based cohort study.
H. Frederiksen, D. Farkas, C. Christiansen, T. Larsen +3 more
2015The Lancet Haematology24 citations Open access
Semantic Scholar
Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort.
J. M. Holst, T. Plesner, M. Pedersen, H. Frederiksen +20 more
2019Haematologica23 citations Open access
Semantic Scholar
Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemia
H. Rajala, M. El Missiry, Anniina Ruusila, P. Koskenvesa +12 more
2017Journal of Cancer Research and Clinical Oncology23 citations Open access
Semantic Scholar
Haemoptysis caused by aneurysm of saphenous bypass graft to a coronary artery.
J. F. Nielsen, J. Stentoft, N. Aunsholt
1988Scandinavian Journal of Thoracic and Cardiovascular Surgery23 citations
Semantic Scholar
Intensive Treatment and Stem Cell Transplantation in Chronic Myelogenous Leukemia: Long-Term Follow-Up
B. Simonsson, G. Öberg, M. Björeman, M. Björkholm +22 more
2005Acta Haematologica22 citations
Semantic Scholar
Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line
A. Kreutzman, B. Yadav, T. Brummendorf, B. Gjertsen +14 more
2019Oncoimmunology21 citations Open access
Semantic Scholar
Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial
Hjalmar Flygt, S. Söderlund, J. Richter, S. Saussele +16 more
2024Leukemia20 citations Open access
Semantic Scholar
A real-time quantitative RT-PCR assay for monitoring DEK-CAN fusion transcripts arising from translocation t(6;9) in acute myeloid leukemia.
M. Østergaard, J. Stentoft, P. Hokland
2004Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis20 citations
Semantic Scholar
Long-Term Efficacy and Safety of Recombinant Interferon Alpha-2 Vs. Hydroxyurea in Polycythemia Vera: Preliminary Results from the Three-Year Analysis of the Daliah Trial - a Randomized Controlled Phase III Clinical Trial
T. Knudsen, D. Hansen, L. F. Ocias, O. Bjerrum +17 more
2018Blood18 citations Open access
Semantic Scholar
Progressive pulmonary fibrosis complicating cyclophosphamide therapy.
J. Stentoft
2009Acta Medica Scandinavica18 citations
Semantic Scholar
IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia
Jani Huuhtanen, M. Ilander, B. Yadav, O. Dufva +22 more
2022Journal of Clinical Investigation17 citations Open access
Semantic Scholar
Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts
O. H. Larsen, J. Stentoft, D. Radia, J. Ingerslev +1 more
2013British Journal of Haematology16 citations
Semantic Scholar
Final Analysis of the Daliah Trial: A Randomized Phase III Trial of Interferon-α Versus Hydroxyurea in Patients with MPN
T. Knudsen, D. Hansen, L. F. Ocias, O. Bjerrum +22 more
2023Blood14 citations Open access
Semantic Scholar
Treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) treated with frontline nilotinib: Results from the ENESTFreedom study.
A. Hochhaus, T. Masszi, F. Giles, J. Radich +16 more
201610 citations
Semantic Scholar
False-negative latex-agglutination test for myoglobin owing to antigen excess.
E. Toft, J. Stentoft, P. Andersen
1988Clinical Chemistry10 citations
Semantic Scholar
Long‐term tolerability and efficacy after initial PegIFN‐α addition to dasatinib in CML‐CP: Five‐year follow‐up of the NordCML007 study
Hjalmar Flygt, S. Söderlund, J. Stentoft, J. Richter +14 more
2021European Journal of Haematology8 citations Open access
Semantic Scholar
ITP: from idiopathic purpura to immune thrombocytopenia and back
J. Stentoft
2016British Journal of Haematology8 citations
Semantic Scholar
Safety and Efficacy of Addition of Pegylated Interferon alpha2b to Standard Dose Dasatinib in Newly Diagnosed Chronic Phase CML Patients
H. Hjorth-Hansen, J. Stentoft, J. Richter, P. Koskenvesa +14 more
20157 citations
Semantic Scholar
Bilateral renal artery stenosis in a patient with chronic myeloid leukemia treated with nilotinib.
Tilde Kristensen, E. Randers, J. Stentoft
2012Leukemia Research Reports7 citations Open access
Semantic Scholar
Molecular cytogenetics investigation of the telomeres in a case of Philadelphia positive B-ALL with a single telomere expansion.
K. Krejčí, J. Stentoft, Jørn Koch
1999Neoplasia7 citations Open access
Semantic Scholar
Low-dose cytosine arabinoside in the treatment of relapsed and refractory acute non-lymphocytic leukaemia.
Mogens Krogh Jensen, J. Stentoft
1986Acta Haematologica7 citations
Semantic Scholar
Healthcare resource utilization in patients with myeloproliferative neoplasms: A Danish nationwide matched cohort study
S. Christensen, L. S. Svingel, A. Kjærsgaard, A. Stenling +13 more
2022European Journal of Haematology6 citations Open access
Semantic Scholar
Labor market affiliation of patients with myeloproliferative neoplasms: a population-based matched cohort study
L. S. Svingel, S. Christensen, A. Kjærsgaard, A. Stenling +12 more
2023Acta oncologica5 citations Open access
Semantic Scholar
How I treat immune thrombocytopenia – a global view
N. Cooper, R. Bird, Y. Chinthammitr, B. George +4 more
2021British Journal of Haematology5 citations Open access
Semantic Scholar
Efficacy and Safety of Front-Line Nilotinib Treatment and Discontinuation in Older Patients (≥65 years) with Chronic Myeloid Leukemia in Chronic Phase Who Have Achieved MR4.5: Results from ENESTfreedom
J. V. García Gutiérrez, J. Radich, A. Hochhaus, G. Saglio +14 more
20204 citations Open access
Semantic Scholar
PF409 DURABILITY AND IMPACT ON QUALITY OF LIFE OF TREATMENT-FREE REMISSION (TFR) IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AFTER STOPPING FRONTLINE (1L) NILOTINIB: ENESTFREEDOM 192-WK RESULTS
D. Ross, T. Masszi, Gómez M. T. Casares, A. Hellmann +14 more
2019HemaSphere4 citations Open access
Semantic Scholar
Treatment-free remission (TFR) following frontline (1L) nilotinib (NIL) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP): 192-week data from the ENESTfreedom study.
F. Giles, T. Masszi, M. Gómez-Casares, A. Hellmann +14 more
2019Journal of Clinical Oncology4 citations
Semantic Scholar
Long-term treatment-free remission (TFR) following frontline (1L) nilotinib in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP): ENESTfreedom 144-wk results.
J. Radich, T. Masszi, M. G. Casares, A. Hellmann +15 more
20184 citations
Semantic Scholar
A Phase IIIb Multicentre Open-Label Study of Nilotinib in Adult Patients with Newly Diagnosed BCR-ABL Positive Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): A European Clinical Initiative with EUTOS Collaboration for Standardisation of Molecular Remission
F. Giles, G. Rosti, G. Ossenkoppele, M. Tulliez +12 more
20114 citations
Semantic Scholar
S1609 THREE-YEAR ANALYSIS OF THE DALIAH TRIAL - A RANDOMIZED CONTROLLED PHASE III CLINICAL TRIAL COMPARING RECOMBINANT INTERFERON ALPHA-2 VS. HYDROXYUREA IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS
T. Knudsen, Lundbek Hansen, Frans L. Ocias, Weis O. Bjerrum +20 more
2019HemaSphere3 citations Open access
Semantic Scholar
A Randomized Phase II Study Comparing Imatinib and the Combination of Imatinib and Pegylated Interferon Alpha-2b in Newly Diagnosed Non-High Risk Chronic Myeloid Leukemia (CML) Patients in Complete Hematological Remission After Imatinib Induction Therapy.
B. Simonsson, T. Gedde-Dahl, B. Markevärn, K. Remes +24 more
20093 citations
Semantic Scholar
Thrombotic Thrombocytopenic Purpura and Evans Syndrome: Validating and Exploring 20 Years of Routine Hospital Care
D. Lawrie, D. Hansen, Thomas Leineweber Kristensen, Sarah Birgitte Ingemod Sand Carlsen +12 more
2025Journal of Blood Medicine2 citations Open access
Semantic Scholar
Disease Activity After Switching From Eculizumab to Ravulizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria: Real World Data From Denmark and Finland
Anders Rønneholt‐Frederiksen, D. Hansen, V. Nummi, J. Stentoft +5 more
2025eJHaem2 citations Open access
Semantic Scholar
Co-shared genomic alterations within tumors from patients with both myeloproliferative neoplasms and lymphoma
J. M. Holst, M. Pedersen, M. B. Enemark, M. C. Hansen +15 more
2024Haematologica2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

H. Hjorth-Hansen×12
Invite
H. Hjorth-Hansen — researcher profile on SciRah
S. Mustjoki×11
Invite
S. Mustjoki — researcher profile on SciRah
L. Stenke×10
Invite
L. Stenke — researcher profile on SciRah
F. Giles×9
Invite
F. Giles — researcher profile on SciRah

×9

Invite

A. Hellmann — researcher profile on SciRah

N. Gattermann×9

Invite

N. Gattermann — researcher profile on SciRah

B. Markevärn×9

Invite

B. Markevärn — researcher profile on SciRah

P. Koskenvesa×9

Invite

P. Koskenvesa — researcher profile on SciRah

Invite

A. Hochhaus — researcher profile on SciRah

Invite

T. Masszi — researcher profile on SciRah

E. Conneally×8

Invite

E. Conneally — researcher profile on SciRah

Invite

B. Martino — researcher profile on SciRah